This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
Les mer
This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis.
Les mer
Anti-HBV drugs in liver cirrhosis.- Anti-HCV drugs in liver cirrhosis.- Anticoagulants in liver cirrhosis.- Antibiotics in liver cirrhosis.- Silymarin in liver cirrhosis.- Ursodeoxycholic acid in liver cirrhosis.- Emricasan in liver cirrhosis.- Non-selective beta blockers in liver cirrhosis.- Somatostatin and octreotide in liver cirrhosis.- Terlipressin in liver cirrhosis.- Diuretics in liver cirrhosis.- Statins in liver cirrhosis.- L-Ornithine L-Aspartate in liver cirrhosis.- Lactulose in liver cirrhosis.
Les mer
This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
Les mer
Presents current and emerging pharmacotherapy for management of liver cirrhosis comprehensively Introduces indications and contra-indications of different types of drug in management of liver cirrhosis Supported by authoritative sources and published clinical trials
Les mer
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Produktdetaljer

ISBN
9789811926143
Publisert
2022-07-27
Utgiver
Vendor
Springer Verlag, Singapore
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet

Om bidragsyterne

Xingshun Qi is an Associate Professor at the Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.Yongping Yang is a Professor at Department of Liver Disease, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.